Dr Reddys Laboratories for purportedly infringing the former’s patented drug Zemplar on six counts, concerning three patents. AbbVie has demanded the court to pass an order to hold back Dr Reddys from commercially manufacturing, using, offering for sale, selling, marketing, distributing, or importing Dr Reddys’ generic paricalcitol injectable products prior to the expiration of said patents.
Get Free MCX Tips, Stock Tips, Forex Tips & NCDEX Tips,Commodity Tips, Share Tips, commodity tips free trial, nifty free tips, commodity trading tips, shares tips, Share Market Tips, Stock Market Tips, free stock tips on mobile, Stock trading tips, Intraday Tips. or login http://www.epicresearch.co/
No comments:
Post a Comment